However, further research is necessary to evaluate the direct impact of these inhibitors on angioma formation and the underlying mechanisms involved, including the modulation of inflammatory cytokines and transcription factors, which are known to regulate both IL-23 and VEGF expression [37]. This evidence concerns the gene IL37 and hemangioma.